Decision Layer
What to do with this topic
Use this page to decide whether insulin sensitivity belongs near the top of your follow-up list or stays in the background.
What to validate first
Fasting insulin, HOMA-IR, C-peptide
Why this topic matters
Insulin sensitivity becomes more useful when it is tied to real markers instead of isolated variants.
How to use this page
Use the decision layer first, then move into genes, biomarkers, and related symptom pages only if the topic still looks relevant.
Why It Rises Or Falls
How this topic earns attention
What this topic can explain
Separate insulin-response strain from the broader glucose bucket so insulin resistance signals can rank on their own.
What usually moves it up the list
Insulin sensitivity rises when INSR and the supporting genes point in a coherent direction, and when the follow-up markers are practical enough to check early.
What usually keeps it in the background
A topic stays lower when the signal depends too heavily on symptoms alone or when other pathways show stronger, more testable drivers.
Validation markers commonly worth checking
Fasting insulin
HOMA-IR
C-peptide
Sample Report View
How Insulin sensitivity appears in the sample report
INSR is the main reason insulin sensitivity rises in the sample report. Additional context comes from IRS2, AKT2, ENPP1.
High follow-up priority
Fasting insulin
This topic belongs near the top of the follow-up list because the signal is concentrated and testable.